Histone deacetylase inhibitors in multiple myeloma

被引:3
|
作者
Pratt, Guy [1 ,2 ]
机构
[1] Univ Birmingham, Sch Canc Sci, Birmingham B15 2TT, W Midlands, England
[2] Birmingham Heartlands Hosp, Dept Haematol, Birmingham B9 5ST, W Midlands, England
来源
LANCET ONCOLOGY | 2013年 / 14卷 / 11期
关键词
D O I
10.1016/S1470-2045(13)70425-X
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1038 / 1039
页数:3
相关论文
共 50 条
  • [1] Histone deacetylase inhibitors in multiple myeloma
    Deleu, Sarah
    Menu, Eline
    Van Valckenborgh, Els
    Van Camp, Ben
    Fraczek, Joanna
    Broek, Isabelle Vande
    Rogiers, Vera
    Vanderkerken, Karin
    [J]. HEMATOLOGY REPORTS, 2009, 1 (01) : 46 - 55
  • [2] Histone deacetylase inhibitors in the treatment for multiple myeloma
    Hideshima, Teru
    Anderson, Kenneth C.
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 97 (03) : 324 - 332
  • [3] Histone deacetylase inhibitors in the treatment for multiple myeloma
    Teru Hideshima
    Kenneth C. Anderson
    [J]. International Journal of Hematology, 2013, 97 : 324 - 332
  • [4] The potential of histone deacetylase inhibitors for the treatment of multiple myeloma
    Prince, H. Miles
    Bishton, Mark
    Harrison, Simon
    [J]. LEUKEMIA & LYMPHOMA, 2008, 49 (03) : 385 - 387
  • [5] New Insights into the Treatment of Multiple Myeloma with Histone Deacetylase Inhibitors
    Cea, Michele
    Cagnetta, Antonia
    Gobbi, Marco
    Patrone, Franco
    Richardson, Paul G.
    Hideshima, Teru
    Anderson, Kenneth C.
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (04) : 734 - 744
  • [6] Clinical use and applications of histone deacetylase inhibitors in multiple myeloma
    Tandon, Nidhi
    Ramakrishnan, Vijay
    Kumar, Shaji K.
    [J]. CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2016, 8 : 35 - 44
  • [7] Histone deacetylase inhibitors in multiple myeloma: from bench to bedside
    Harada, Takeshi
    Hideshima, Teru
    Anderson, Kenneth C.
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2016, 104 (03) : 300 - 309
  • [8] Role of Histone Deacetylase Inhibitors in the Treatment of Lymphomas and Multiple Myeloma
    Zain, Jasmine
    [J]. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2012, 26 (03) : 671 - +
  • [9] Histone deacetylase inhibitors in multiple myeloma: from bench to bedside
    Takeshi Harada
    Teru Hideshima
    Kenneth C. Anderson
    [J]. International Journal of Hematology, 2016, 104 : 300 - 309
  • [10] The role of histone deacetylase inhibitors in patients with relapsed/refractory multiple myeloma
    Hajek, Roman
    Siegel, David
    Orlowski, Robert Z.
    Ludwig, Heinz
    Palumbo, Antonio
    Dimopoulos, Meletios
    [J]. LEUKEMIA & LYMPHOMA, 2014, 55 (01) : 11 - 18